Literature DB >> 21547108

Evaluation of Four Bedside Test Systems for Card Performance, Handling and Safety.

Felix Giebel1, Susanne M Picker, Birgit S Gathof.   

Abstract

SUMMARY:
OBJECTIVE: Pretransfusion ABO compatibility testing is a simple and required precaution against ABO-incompatible transfusion, which is one of the greatest threats in transfusion medicine. While distinct agglutination is most important for correct test interpretation, protection against infectious diseases and ease of handling are crucial for accurate test performance. Therefore, the aim of this study was to evaluate differences in test card design, handling, and user safety.
DESIGN: Four different bedside test cards with pre-applied antibodies were evaluated by 100 medical students using packed red blood cells of different ABO blood groups. Criteria of evaluation were: agglutination, labelling, handling, and safety regarding possible user injuries. Criteria were rated subjectively according to German school notes ranging from 1 = very good to 6 = very bad/insufficient.
RESULTS: Overall, all cards received very good/good marks. The ABO blood group was identified correctly in all cases. Three cards (no. 1, no. 3, no. 4) received statistically significant (p < 0.008) prominence (mean values shown) concerning clearness of agglutination (1.7-1.9 vs. 2.4 for no. 2). Systems with dried antibodies (no. 2, no. 4) outmatched the other systems with respect to overall test system performance (2.0 vs. 2.8-2.9), labelling (1.5 vs. 2.2-2.4), handling (1.9-2.0 vs. 2.5), and user safety (2.5 vs. 3.4). Analysis of card self-explanation revealed no remarkable differences.
CONCLUSION: Despite good performance of all card systems tested, the best results when including all criteria evaluated were obtained with card no. 4 (particularly concerning clear agglutination), followed by cards no. 2, no. 1, and no. 3.

Entities:  

Year:  2007        PMID: 21547108      PMCID: PMC3083278          DOI: 10.1159/000111385

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  21 in total

1.  Errors in interpreting the pretransfusion bedside compatibility test: an experimental study.

Authors:  P P Dujardin; L R Salmi; P Ingrand
Journal:  Vox Sang       Date:  2000       Impact factor: 2.144

2.  [Immunologic risk analysis of blood transfusion: 1991-1998].

Authors:  P Rouger; P Y Le Pennec; F Noizat-Pirenne
Journal:  Transfus Clin Biol       Date:  2000-02       Impact factor: 1.406

Review 3.  Pretransfusion compatibility testing for red blood cell administration.

Authors:  I A Shulman; K A Downes; K Sazama; L M Maffei
Journal:  Curr Opin Hematol       Date:  2001-11       Impact factor: 3.284

4.  The risk of transfusion to the wrong patient in Germany.

Authors:  Gregor Caspari; Uta Alpen; Andreas Greinacher
Journal:  Transfusion       Date:  2002-09       Impact factor: 3.157

5.  [Technical methods for the ultimate verification at the patient's bedside].

Authors:  P Y Le Pennec; P Rouger
Journal:  Rev Fr Transfus Hemobiol       Date:  1991-03

Review 6.  Non-infectious complications of transfusion therapy.

Authors:  P L Perrotta; E L Snyder
Journal:  Blood Rev       Date:  2001-06       Impact factor: 8.250

7.  [Securing the ABO-identity by serafol before blood transfusions (author's transl)].

Authors:  H Uthemann; M Weber
Journal:  Anaesthesist       Date:  1982-04       Impact factor: 1.041

8.  [Introduction of a new card for the "bedside test"].

Authors:  E Meinshausen; M Wendt
Journal:  Anaesthesist       Date:  1989-10       Impact factor: 1.041

9.  Transfusion errors in New York State: an analysis of 10 years' experience.

Authors:  J V Linden; K Wagner; A E Voytovich; J Sheehan
Journal:  Transfusion       Date:  2000-10       Impact factor: 3.157

10.  Factors associated with nurses' poor knowledge and practice of transfusion safety procedures in Aquitaine, France.

Authors:  F Saillour-Glénisson; S Tricaud; S Mathoulin-Pélissier; B Bouchon; I Galpérine; P Fialon; L R Salmi
Journal:  Int J Qual Health Care       Date:  2002-02       Impact factor: 2.038

View more
  1 in total

1.  Red Blood Cell Agglutination for Blood Typing Within Passive Microfluidic Biochips.

Authors:  Maxime Huet; Myriam Cubizolles; Arnaud Buhot
Journal:  High Throughput       Date:  2018-04-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.